Open access · CC-BY
via OpenAlex
Chronic <scp>mTOR</scp> inhibition in mice with rapamycin alters <scp>T</scp> , <scp>B</scp> , myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice
Vincent Hurez, Vinh Dao, Aijie Liu, Srilakshmi Pandeswara, Jonathan Gelfond, Lishi Sun, Molly A. Bergman, Carlos J. Orihuela, Verónica Galván, Álvaro Padrón, Justin Drerup, Yang Liu, Paul Hasty, Z. Dave Sharp, Tyler J. Curiel
Aging Cell · 2015 · ▲ 126 citations
Deregulated nutrient-sensing
Chronic inflammation
Rapamycin / mTOR inhibition
Cell culture / in vitro
Human
Mouse
In vitro
Abstract
The mammalian (mechanistic) target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (mTOR) regulates critical immune processes that remain incompletely defined. Interest in mTOR inhibitor drugs is heightened by recent demonstrations that the mTOR inhibitor rapamycin extends lifespan and healthspan(definition) in mice. Rapamycin or related analogues (rapalogues) also mitigate age-related debilities including increasing antigen-specific immunity, improving vaccine responses in elderly humans, and treating cancers and autoimmunity, suggesting important new clinical applications. Nonetheless, immune toxicity concerns for long-term mTOR inhibition, particularly immunosuppression, persist. Although mTOR is pivotal to fundamental, important immune pathways, little is reported on immune effects of mTOR inhibition in lifespan or healthspan extension, or with chronic mTOR inhibitor use. We comprehensively analyzed immune effects of rapamycin as used in lifespan extension studies. Gene expression profiling found many and novel changes in genes affecting differentiation, function, homeostasis, exhaustion, cell death, and inflammation in distinct T- and B-lymphocyte and myeloid cell subpopulations. Immune functions relevant to aging and inflammation, and to cancer and infections, and innate lymphoid cell effects were validated in vitro and in vivo. Rapamycin markedly prolonged lifespan and healthspan in cancer- and infection-prone mice supporting disease mitigation as a mechanism for mTOR suppression-mediated longevity extension. It modestly altered gut metagenomes, and some metagenomic effects were linked to immune outcomes. Our data show novel mTOR inhibitor immune effects meriting further studies in relation to longevity and healthspan extension.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.12380
- Canonical
- link ↗
- Fetched
- 2026-06-13 MST
Cite this
APA
Hurez, V., Dao, V., Liu, A., Pandeswara, S., Gelfond, J., Sun, L., Bergman, M.A., Orihuela, C.J., Galván, V., Padrón, �., Drerup, J., Liu, Y., Hasty, P., Sharp, Z.D., & Curiel, T.J. (2015). Chronic <scp>mTOR</scp> inhibition in mice with rapamycin alters <scp>T</scp> , <scp>B</scp> , myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice. <em>Aging Cell</em>. https://doi.org/10.1111/acel.12380
Vancouver
Hurez V, Dao V, Liu A, Pandeswara S, Gelfond J, Sun L, et al. Chronic <scp>mTOR</scp> inhibition in mice with rapamycin alters <scp>T</scp> , <scp>B</scp> , myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice. Aging Cell. 2015. doi:10.1111/acel.12380.
BibTeX
@article{vincent2015Chroni,
title = {Chronic <scp>mTOR</scp> inhibition in mice with rapamycin alters <scp>T</scp> , <scp>B</scp> , myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice},
author = {Vincent Hurez and Vinh Dao and Aijie Liu and Srilakshmi Pandeswara and Jonathan Gelfond and Lishi Sun and Molly A. Bergman and Carlos J. Orihuela and Verónica Galván and Álvaro Padrón and Justin Drerup and Yang Liu and Paul Hasty and Z. Dave Sharp and Tyler J. Curiel},
journal = {Aging Cell},
year = {2015},
doi = {10.1111/acel.12380},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Clinical Investigation 2013
Open access · OA
Rapamycin extends murine lifespan but has limited effects on aging
Aging Cell 2013
Open access · CC-BY
<scp>TORC</scp>1 signaling inhibition by rapamycin and caffeine affect lifespan, global gene expression, and cell proliferation of fission yeast
Nature Communications 2020
Open access · CC-BY
The mTOR pathway is necessary for survival of mice with short telomeres
Nature Communications 2019
Open access · CC-BY
A novel rapamycin analog is highly selective for mTORC1 in vivo
The Journals of Gerontology Series A 2016
Open access · OA
Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island
Neuroscience 2012
Citation only